Skip to main content
Clinical Trials/NCT01334619
NCT01334619
Completed
Phase 4

Ropivacaine Volume for Ultrasound-guided Retrograde Infraclavicular Brachial Plexus Block

Beijing Jishuitan Hospital1 site in 1 country30 target enrollmentMarch 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Upper Extremity Injury Trauma
Sponsor
Beijing Jishuitan Hospital
Enrollment
30
Locations
1
Primary Endpoint
VAS of brachial plexus innervated area
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The retrograde infraclavicular brachial plexus block has been proved an effective and safe approach. Realtime ultrasound guide will facilitate a successful peripheral nerve block. The purpose of this study was to determine the medium effective volume required to produce an effective retrograde infraclavicular block using an ultrasound (US)-guided technique.

Detailed Description

Thirty adults undergoing elective upper limb surgery received an US-guided retrograde infraclavicular block. The initial concentration of 0.5% ropivacaine injected was 30 ml, which was subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient. The medium effective volume (EV50) was determined using the Dixon and Massey up-and-down method. The effective volume in 95% of patients (EV95) was calculated using probit regression.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
May 2010
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Elected upper extremity operations
  • BMI 17\~30kg/m2

Exclusion Criteria

  • Infection at injection site
  • Coagulation Dysfunction
  • Phrenic nerve palsy
  • Pneumothorax
  • Recurrent laryngeal nerve palsy
  • Clavicle fracture combined with nerve damage

Outcomes

Primary Outcomes

VAS of brachial plexus innervated area

Time Frame: 20 minutes

effect and side effects of the present block approach for brachial plexus.

Secondary Outcomes

  • medium effective ropivacaine volume(about 2 months)

Study Sites (1)

Loading locations...

Similar Trials